[1] Asai A, Miethke A, Bezerra J A . Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes. Nat Rev Gastroenterol Hepatol, 2015, 12(6):342-352. [2] Zani A, Quaglia A, Hadzić N, et al. Cytomegalovirus-associated biliary atresia: An aetiological and prognostic subgroup. J Pediatr Surg, 2015, 50(10):1739-1745. [3] 于洪丽, 喻文立, 翁亦齐,等. 不同麻醉方式对胆道闭锁患儿亲体肝移植术后谵妄的影响. 中华麻醉学杂志, 2020, 40(10):1175-1178. [4] 刘立伟, 刘纪民, 罗娟,等. 胆道闭锁葛西手术后肝内T淋巴细胞与Th17及CD8+T淋巴细胞比例失衡参与疾病进展. 中华肝脏病杂志, 2021, 29(2):150-155. [5] Clemente MG, Garzi A, VajroP. Clinicians should remain vigilant for biliary atresia as early diagnosis and surgery are vital. Acta paediatr, 2019, 108(12):2129-2131. [6] Pakarinen M P, Johansen L S, Svensson J F, et al. Outcomes of biliary atresia in the nordic countries - a multicenter study of 158 patients during 2005-2016. J Pediatr Surg, 2017, 53(8):1509-1515. [7] Fujishiro J, Urita Y, Shinkai T, et al. Clinical characteristics of liver fibrosis in patients with choledochal cysts. J Pediatr Surg, 2011, 46(12):2296-2300. [8] Yang L, Tatsuki M, Pranavkumar S, et al. Regulation of epithelial injury and bile duct obstruction by NLRP3 and IL-1R1 in experimental biliary atresia. J Hepatol, 2018, 69(5):1136-1144. [9] Zhou L Y, Jiang H, Shan Q Y, et al. Liver stiffness measurements with supersonic shear wave elastography in the diagnosis of biliary atresia: a comparative study with grey-scale US. Eur Radiol, 2017, 27(8):3474-3484. [10] 陈小爱, 杨继鑫, 冯杰雄. 胆道闭锁病因及其发病机制研究进展. 中华实用儿科临床杂志, 2015, 30(19):1516-1518. [11] Li XM, He PJ, Li SZ, et al. Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2/9, TIMP1/2 and the TGF-β/Smad signaling pathways. Acta Pharmacol Sin, 2016, 37(6):783-793. [12] Domitrović C, Jakovac R, Marchesi H V, et al. Resolution of liver fibrosis by isoquinoline alkaloid berberine in CCl4-intoxicated mice is mediated by up-regulation of MMP-2 expression. J Med Food, 2013, 16(6):518-528. [13] Kennedy L, Francis H L, Meng F, et al. 510 microRNA-21 increases liver fibrosis via modulation of TGF-β1/SMAD signaling in bile duct ligated (BDL) mice. Gastroenterology, 2016, 150(4):1038-1039. [14] Wu N, Meng F, Invernizzi P, et al. The secretin/secretin receptor axis modulates liver fibrosis through changes in TGF-β1 biliary secretion. Hepatology, 2016, 64(3):865-879. [15] Sayyed H G, Osama A, Idriss N K, et al. Comparison of the therapeutic effectiveness of human CD34+ and rat bone marrow mesenchymal stem cells on improvement of experimental liver fibrosis in Wistar rats. Int J Physiol Pathophysiol Pharmacol, 2019, 8(3):128-139. [16] Burch M L, Zheng W, Little P J . Smad linker region phosphorylation in the regulation of extracellular matrix synthesis. Cell Mol Life Sci, 2011, 68(1):97-107. [17] Iordanskaia T, Hubal M J, Koeck E, et al. Dysregulation of upstream and downstream transforming growth factor-β transcripts in livers of children with biliary atresia and fibrogenic gene signatures. J Am Coll Surgeons, 2013, 48(10):2047-2053. [18] 董淳强, 董昆, 杨体泉. 基质金属蛋白酶2在胆道闭锁患儿肝组织中的表达. 中华实用儿科临床杂志, 2013, 28(23):1801-1804. [19] Shimadera S, Iwai N, Deguchi E, et al. Predicting factors on the occurrence of cystic dilatation of intrahepatic biliary system in biliary atresia. Pediate Surg Inter, 2010, 26(6):611-614. [20] Yamaguti D, Patrício FRDS. Morphometrical and immunohistochemical study of intrahepatic bile ducts in biliary atresia. Eur J Gastroenterol Hepatol, 2011, 23(9):759-765. |